Estimation of the hepcidin level and some Biochemical parameters in patients of polycystic ovary Syndrome in Kirkuk city
Main Article Content
Abstract
Polycystic ovary Syndrome is a common disorder in the endocrine glands, which is characterized by the aggregation of small bags surrounded by theca internal layers bloated follicles .
The level of hepcidin and some other biochemical parameters were examined in (60) patients In addition to (30) blood samples of healthy control .
The results showed a significant decrease in hepcidin level as well as E2 and progesterone while there was a significant increase in prolactin and testosterone in polycystic ovarian syndrome patients Compared to healthy control. There was no correlation between hepcidin and all other parameters but there was some correlations among parameters used, there was positive correlations between FSH with LH and Testosterone as well as between E2 and Testosterone and between T4 and T3 .
Article Details

This work is licensed under a Creative Commons Attribution 4.0 International License.
Tikrit Journal of Pure Science is licensed under the Creative Commons Attribution 4.0 International License, which allows users to copy, create extracts, abstracts, and new works from the article, alter and revise the article, and make commercial use of the article (including reuse and/or resale of the article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made, and the licensor is not represented as endorsing the use made of the work. The authors hold the copyright for their published work on the Tikrit J. Pure Sci. website, while Tikrit J. Pure Sci. is responsible for appreciate citation of their work, which is released under CC-BY-4.0, enabling the unrestricted use, distribution, and reproduction of an article in any medium, provided that the original work is properly cited.
References
[1] Brown, H.M. and Russell, D.L, (2013). Blood and lymphatic vasculature in the Ovary: Development, function and disease, Human Reproduction Update, (20):29.
[2] Sherwood, L. (2013), Human Physiology: From Cells to systems (8th edn.) Belmont, CA: Cen gage: 735-794.
[3] Epping, J.; Wigglesworth, K. and Pendola, F. (2002). The mammalian oocyte orchestrates the rate of ovarian follicular development. Proc. Natl. Acad. Sci., (99):2890-2894.
[4] Jiawei, X.B et al. (2016). Comprehensive analysis of genome-wide DNA methylation across human polycystic ovary syndrome ovary granulosa cell, Oncotarget, 7(19).
[5] Yong-ll, J. and Min J.K. (2015). Polycystic Ovary syndrome, 30(2):109-114.
[6] Rebar, R.; Judd, H.L. and Yen, S.S. (1976). Characterization of the inappropriate gonaclotr, ptzin secrotion in polycystic ovary Syndrome, Jclin Invest, (57):1320-1329.
[7] Duraid, J.T. and Wedad, M.L. (2017). DETERMINATION OF HEPCIDIN CONCINTRATION AND MANY HEMATOLOGICAL AND BIOCHEMICAL VARIATIONS IN PATIENTS WITH DIABETESTYPE 2 IN BALAD CITY, Education for pure science, 22(3):1-6.
[8] Antonello, P. (2015). Genetic Testing, and Management of Hemochromatosis: 15 Years Since Hepcidin, Genetics,149(5):1240-1251.
[9] Manuel, L.F.; Macarena, A.S. and He, F.E. (2011). Role of Decreased Circulating Hepcidin Concentrations in the Iron Excess of Women with the Polycystic Ovary Syndrome, 96(3):846–852.
[10] Hossein, R.B. et al. (2017). Evaluation of serum hepcidin and iron levels in patients with PCOS: a case-control study, Italian Society of Endocrinology: 1–6.
[11] Kamila, H.S.; Hedef, D.E. and Haider, A.S. (2009). Serum resistin levels and other hormonal and biochemical parameters in patients with polycystic ovary syndrome, PCOS., 51(2).
[12] Nawras, N.B.; Shams, E.D. and Sana, A.H. (2014). Study of the Hormonal Reproductive exchenges associated with Polycystic Ovary Syndrome in women of reproductive age in Najaf city. 6(3):1-7.
[13] Hussein, K.H. (2012). Correlation Between Iron Status Parameters and Hormone Levels in Women with Polycystic Ovary Syndrome.
[14] Wasan, W.I.; Raya, Kh.S. and Widad, M.A. (2016). Serum Prostate Specific Antigen level in Women with Polycystic Ovary Syndrome, 58(2).
[15] Thomas, M.A. and Rebar, R.W. (1997). Delayed puberty in girls and Primary amenorrhea, Journal Endo. Craniology and Metabolism, (6):233-226.
[16] Shaza, M. et al. (2017). Thyroid function/ antibodies in sudanese women with polycystic ovarian disease, 60(2):187-192.
[17] Kazuk, R.; Kazawwa, S. and Orio, N. (2008). Hypothyrodism with Poly Cystic Ovary Syndrome, Journal Clin. Endocrinol, 6(3):431-439.
[18] Dimitrios, P. et al. (2003). Serum adiponectin levels in women with Polycystic Ovary Syndrome, 18(9):1790-1796.